BIOMAT Database Logo BIOMAT Database Logo

[Control of heparin and protamine administration (author's transl)]. 1979

I Yuge, and N Fujii, and M Yamada, and N Anzai

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011479 Protamines A group of simple proteins that yield basic amino acids on hydrolysis and that occur combined with nucleic acid in the sperm of fish. Protamines contain very few kinds of amino acids. Protamine sulfate combines with heparin to form a stable inactive complex; it is used to neutralize the anticoagulant action of heparin in the treatment of heparin overdose. (From Merck Index, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p692) Protamine,Protamine Sulfate,Protamine Chloride,Chloride, Protamine,Sulfate, Protamine
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005112 Extracorporeal Circulation Diversion of blood flow through a circuit located outside the body but continuous with the bodily circulation. Circulation, Extracorporeal,Circulations, Extracorporeal,Extracorporeal Circulations
D005260 Female Females
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

I Yuge, and N Fujii, and M Yamada, and N Anzai
[Subcutaneous administration of heparin (author's transl)].
February 1982, [Rinsho ketsueki] The Japanese journal of clinical hematology,
I Yuge, and N Fujii, and M Yamada, and N Anzai
[Cardiac arrest following protamine sulphate administration (author's transl)].
January 1981, Wiener klinische Wochenschrift,
I Yuge, and N Fujii, and M Yamada, and N Anzai
[Protamine dosage for heparin neutralization in open-heart surgery (author's transl)].
November 1974, Fukuoka igaku zasshi = Hukuoka acta medica,
I Yuge, and N Fujii, and M Yamada, and N Anzai
Platelet aggregation following heparin and protamine administration.
January 1978, Anesthesiology,
I Yuge, and N Fujii, and M Yamada, and N Anzai
[Long-term administration of calcium-heparin in thromboembolism (author's transl)].
January 1980, Annales de medecine interne,
I Yuge, and N Fujii, and M Yamada, and N Anzai
[Effect of low-dose-heparin and its control (author's transl)].
April 1976, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
I Yuge, and N Fujii, and M Yamada, and N Anzai
Probable reversal of protamine reactions by heparin administration.
October 1990, Journal of cardiothoracic anesthesia,
I Yuge, and N Fujii, and M Yamada, and N Anzai
[Mode of action and control of "low dose heparin" (author's transl)].
March 1977, Medizinische Klinik,
I Yuge, and N Fujii, and M Yamada, and N Anzai
Safety issues in heparin and protamine administration for extracorporeal circulation.
April 1998, Journal of cardiothoracic and vascular anesthesia,
I Yuge, and N Fujii, and M Yamada, and N Anzai
[Biochemistry of heparin (author's transl)].
July 1981, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!